Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer

R. M. Subramaniam, M. Truong, P. Peller, O. Sakai, G. Mercier

Research output: Contribution to journalReview article

72 Citations (Scopus)

Abstract

The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.

Original languageEnglish (US)
Pages (from-to)598-604
Number of pages7
JournalAmerican Journal of Neuroradiology
Volume31
Issue number4
DOIs
StatePublished - Apr 1 2010

Fingerprint

Squamous Cell Neoplasms
Head and Neck Neoplasms
Positron-Emission Tomography
Head
Unknown Primary Neoplasms
Neoplasm Metastasis
Neoplasms
Information Management
Radiotherapy
Lymph Nodes
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging

Cite this

Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. / Subramaniam, R. M.; Truong, M.; Peller, P.; Sakai, O.; Mercier, G.

In: American Journal of Neuroradiology, Vol. 31, No. 4, 01.04.2010, p. 598-604.

Research output: Contribution to journalReview article

Subramaniam, R. M. ; Truong, M. ; Peller, P. ; Sakai, O. ; Mercier, G. / Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. In: American Journal of Neuroradiology. 2010 ; Vol. 31, No. 4. pp. 598-604.
@article{3bd7886c1e244394892e9318196eb119,
title = "Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer",
abstract = "The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.",
author = "Subramaniam, {R. M.} and M. Truong and P. Peller and O. Sakai and G. Mercier",
year = "2010",
month = "4",
day = "1",
doi = "10.3174/ajnr.A1760",
language = "English (US)",
volume = "31",
pages = "598--604",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "4",

}

TY - JOUR

T1 - Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer

AU - Subramaniam, R. M.

AU - Truong, M.

AU - Peller, P.

AU - Sakai, O.

AU - Mercier, G.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.

AB - The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.

UR - http://www.scopus.com/inward/record.url?scp=77950787099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950787099&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A1760

DO - 10.3174/ajnr.A1760

M3 - Review article

C2 - 19910448

AN - SCOPUS:77950787099

VL - 31

SP - 598

EP - 604

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 4

ER -